Inhibition of Candida albicans in vivo and in vitro by antimicrobial peptides chromogranin A-N12 through microRNA-155/suppressor of cytokine signaling 1 axis

References

• Aaron L, Torsten M. Candida albicans in celiac disease: a wolf in sheep’s clothing. Autoimmun Rev. 2020;19:102621.
   PubMed Web of Science ®Google Scholar
• Chen H, Zhou X, Ren B, et al. The regulation of hyphae growth in Candida albicans. Virulence. 2020;11:337–348.
   PubMed Web of Science ®Google Scholar
• Dadar M, Tiwari R, Karthik K, et al. Candida albicans - Biology, molecular characterization, pathogenicity, and advances in diagnosis and control - An update. Microb Pathog. 2018;117:128–138.
   PubMed Web of Science ®Google Scholar
• Pellon A, Sadeghi Nasab SD, Moyes DL. New insights in Candida albicans innate immunity at the mucosa: toxins, epithelium, metabolism, and beyond. Front Cell Infect Microbiol. 2020;10:81.
   PubMed Web of Science ®Google Scholar
• Majdabadi N, Falahati M, Heidarie-Kohan F, et al. Effect of 2-phenylethanol as antifungal agent and common antifungals (amphotericin b, fluconazole, and itraconazole) on Candida species isolated from chronic and recurrent cases of Candidal vulvovaginitis. Assay Drug Dev Technol. 2018;16:141–149.
   PubMed Web of Science ®Google Scholar
• Kubica TF, Denardi LB, Azevedo MI, et al. Antifungal activities of tacrolimus in combination with antifungal agents against fluconazole-susceptible and fluconazole-resistant Trichosporon asahii isolates. Braz J Infect Dis. 2016;20:539–545.
   PubMed Web of Science ®Google Scholar
• Browne K, Chakraborty S, Chen R, et al. A new era of antibiotics: the clinical potential of antimicrobial peptides. Int J Mol Sci. 2020;21:7047–7069.
   PubMed Web of Science ®Google Scholar
• Niu JY, Yin WWKK IX, Li QL, et al. Antimicrobial peptides for the prevention and treatment of dental caries: a concise review. Arch Oral Biol. 2021;122:105022.
   PubMed Web of Science ®Google Scholar
• Kurpe SR, Grishin SY, Surin AK, et al. Antimicrobial and amyloidogenic activity of peptides. Can antimicrobial peptides be used against SARS-CoV-2? Int J Mol Sci. 2020;21:9552–9588.
   PubMed Web of Science ®Google Scholar
• Ku YS, Cheng SS, Gerhardt A, et al. Secretory peptides as bullets: effector peptides from pathogens against antimicrobial peptides from soybean. Int J Mol Sci. 2020;21:9294–9319.
   PubMed Web of Science ®Google Scholar
• Srivastava S, Dashora K, Ameta KL, et al. Cysteine-rich antimicrobial peptides from plants: the future of antimicrobial therapy. Phytother Res. 2021;35:256–277.
   PubMed Web of Science ®Google Scholar
• Pasqua T, Rocca C, Spena A, et al. Modulation of the coronary tone in the expanding scenario of Chromogranin-A and its derived peptides. Future Med Chem. 2019;11:1501–1511.
   PubMed Web of Science ®Google Scholar
• Herold Z, Doleschall M, Kovesdi A, et al. Chromogranin A and its role in the pathogenesis of diabetes mellitus. Endokrynol Pol. 2018;69:598–610.
   PubMed Web of Science ®Google Scholar
• Li RF, Lu ZF, Sun YN, et al. Molecular design, structural analysis and antifungal activity of derivatives of peptide CGA-N46. Interdiscip Sci. 2016;8:319–326.
   PubMed Web of Science ®Google Scholar
• Li R, Zhang L, Zhang H, et al. Protective effect of a novel antifungal peptide derived from human chromogranin a on the immunity of mice infected with Candida krusei. Exp Ther Med. 2017;13:2429–2434.
   PubMed Web of Science ®Google Scholar
• Li RF, Wang B, Liu S, et al. Optimization of the expression conditions of CGA-N46 in Bacillus subtilis DB1342(p-3N46) by response surface methodology. Interdiscip Sci. 2016;8:277–283.
   PubMed Web of Science ®Google Scholar
• Li RF, Wang B, Liu S, et al. Optimization of the expression conditions of CGA-N46 in Bacillus subtilis DB1342(p-3N46) by response surface methodology. Interdiscip Sci. 2015:277–283.
   PubMed Web of Science ®Google Scholar
• Li R, Zhao J, Huang L, et al. Antimicrobial peptide CGA-N12 decreases the Candida tropicalis mitochondrial membrane potential via mitochondrial permeability transition pore. Biosci Rep. 2020;40:1–9.
   Web of Science ®Google Scholar
• Li R, Shi W, Zhang R, et al. Effects of CGA-N12 on the membrane structure of Candida tropicalis cells. Biochem J. 2020;477:1813–1825.
   PubMed Web of Science ®Google Scholar
• Li X, Fan Y, Lin Q, et al. Expression of chromogranin A-derived antifungal peptide CGA-N12 in Pichia pastoris. Bioengineered. 2020;11:318–327.
   PubMed Web of Science ®Google Scholar
• Li R, Zhang R, Yang Y, et al. CGA-N12, a peptide derived from chromogranin A, promotes apoptosis of Candida tropicalis by attenuating mitochondrial functions. Biochem J. 2018;475:1385–1396.
   PubMed Web of Science ®Google Scholar
• Montoya AM, Sanchez Gonzalez A, Palma-Nicolas JP, et al. Genotyping, extracellular compounds, and antifungal susceptibility testing of Trichosporon asahii isolated from Mexican patients. Med Mycol. 2015;53:505–511.
   PubMed Web of Science ®Google Scholar
• Gamaletsou MN, Meletiadis J, Chatziioannou S, et al. Experimental Candida albicans osteomyelitis: microbiologic, antigenic, histologic, and 18FDG-PET-CT imaging characteristics in a newly established rabbit model. Med Mycol. 2019;57:1011–1017.
   PubMed Web of Science ®Google Scholar
• Patterson TF, Fothergill AW, Rinaldi MG. Efficacy of itraconazole solution in a rabbit model of invasive aspergillosis. Antimicrob Agents Chemother. 1993;37:2307–2310.
   PubMed Web of Science ®Google Scholar
• Basas J, Palau M, Gomis X, et al. Efficacy of liposomal amphotericin B and anidulafungin using an antifungal lock technique (ALT) for catheter-related Candida albicans and Candida glabrata infections in an experimental model. PLoS One. 2019;14:e0212426.
   PubMed Web of Science ®Google Scholar
• Neris RLS, Dobles AMC, Gomes AV. Western blotting using in-gel protein labeling as a normalization control: advantages of stain-free technology. Methods Mol Biol. 2021;2261:443–456.
   PubMedGoogle Scholar
• Domingues MM, Santos NC, Castanho MA. Antimicrobial peptide rBPI21: a translational overview from bench to clinical studies. Curr Protein Pept Sci. 2012;13:611–619.
   PubMed Web of Science ®Google Scholar
• Murugan RN, Jacob B, Kim EH, et al. Non hemolytic short peptidomimetics as a new class of potent and broad-spectrum antimicrobial agents. Bioorg Med Chem Lett. 2013;23:4633–4636.
   PubMed Web of Science ®Google Scholar
• Vestergaard M, Nohr-Meldgaard K, Bojer MS, et al. Inhibition of the ATP synthase eliminates the intrinsic resistance of staphylococcus aureus towards polymyxins. mBio. 2017;8:17–26.
   Web of Science ®Google Scholar
• Sakoulas G, Bayer AS, Pogliano J, et al. Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother. 2012;56:838–844.
   PubMed Web of Science ®Google Scholar
• Wang F, Qiao L, Lv X, et al. Alarmin human alpha defensin HNP1 activates plasmacytoid dendritic cells by triggering NF-kappaB and IRF1 signaling pathways. Cytokine. 2016;83:53–60.
   PubMed Web of Science ®Google Scholar
• Li R, Liu Z, Dong W, et al. The antifungal peptide CGA-N12 inhibits cell wall synthesis of Candida tropicalis by interacting with KRE9. Biochem J. 2020;477:747–762.
   PubMed Web of Science ®Google Scholar
• Xu K, Wang H, Liu L, et al. Efficacy of CG(3)R(6)TAT nanoparticles self-assembled from a novel antimicrobial peptide for the treatment of Candida albicans meningitis in rabbits. Chemotherapy. 2011;57:417–425.
   PubMed Web of Science ®Google Scholar
• Hirschfield GM, Xie G, Lu E, et al. Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes. Genes Immun. 2012;13:328–335.
   PubMed Web of Science ®Google Scholar
• Juskevicius D, Jucker D, Klingbiel D, et al. Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort. J Hematol Oncol. 2017;10:70.
   PubMed Web of Science ®Google Scholar
• Chikuma S, Kanamori M, Mise-Omata S, et al. Suppressors of cytokine signaling: potential immune checkpoint molecules for cancer immunotherapy. Cancer Sci. 2017;108:574–580.
   PubMed Web of Science ®Google Scholar